AU6803494A - Anticancer compounds - Google Patents

Anticancer compounds

Info

Publication number
AU6803494A
AU6803494A AU68034/94A AU6803494A AU6803494A AU 6803494 A AU6803494 A AU 6803494A AU 68034/94 A AU68034/94 A AU 68034/94A AU 6803494 A AU6803494 A AU 6803494A AU 6803494 A AU6803494 A AU 6803494A
Authority
AU
Australia
Prior art keywords
anticancer compounds
anticancer
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68034/94A
Inventor
John Edward Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939311719A external-priority patent/GB9311719D0/en
Priority claimed from GB939311717A external-priority patent/GB9311717D0/en
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Publication of AU6803494A publication Critical patent/AU6803494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
AU68034/94A 1993-06-07 1994-06-01 Anticancer compounds Abandoned AU6803494A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9311719 1993-06-07
GB939311719A GB9311719D0 (en) 1993-06-07 1993-06-07 Anti-cancer compounds
GB9311717 1993-06-07
GB939311717A GB9311717D0 (en) 1993-06-07 1993-06-07 Anti-cancer compounds
PCT/GB1994/001185 WO1994029327A1 (en) 1993-06-07 1994-06-01 Anticancer compounds

Publications (1)

Publication Number Publication Date
AU6803494A true AU6803494A (en) 1995-01-03

Family

ID=26303016

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68034/94A Abandoned AU6803494A (en) 1993-06-07 1994-06-01 Anticancer compounds

Country Status (3)

Country Link
AU (1) AU6803494A (en)
GB (1) GB2278843A (en)
WO (1) WO1994029327A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2182228C (en) * 1994-01-28 2008-09-16 Paul Ashton Codrugs as a method of controlled drug delivery
JP4903922B2 (en) * 1997-05-14 2012-03-28 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ Complex compounds that degrade selected proteins
FR2818908B1 (en) * 2000-12-29 2004-04-02 Dospharma USE AS A MEDICAMENT OF A COMPOUND RESTITUTING IN VIVO ACTIVE INGREDIENTS
CA2472188C (en) * 2002-01-18 2011-06-21 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
CN102219812B (en) * 2011-04-14 2014-04-09 中国药科大学 Tumor targeting deoxyglucose composite drug and preparation method thereof
MX2018002514A (en) * 2015-09-22 2018-08-15 Univ California Modified cytotoxins and their therapeutic use.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2201419A (en) * 1987-02-24 1988-09-01 Erba Farmitalia Anthracycline-oestrone derivatives
DE3907290A1 (en) * 1989-03-07 1990-09-13 Gerhard Prof Dr Eisenbrand STEROID HORMONE RECEPTOR AFFINES ANTITUARY ACTIVE SUBSTANCES
US5149794A (en) * 1990-11-01 1992-09-22 State Of Oregon Covalent lipid-drug conjugates for drug targeting
WO1992014493A1 (en) * 1991-02-20 1992-09-03 Christopher Capelli Non-protein intracellular receptor binding conjugates and a method of use thereof

Also Published As

Publication number Publication date
GB2278843A (en) 1994-12-14
GB9410907D0 (en) 1994-07-20
WO1994029327A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU1272295A (en) Proinsulin-like compounds
AU6971794A (en) Novel compounds
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU6710294A (en) Tetrahydro-beta-carbolines
AU6705294A (en) Tetrahydro-pyrido-indole
AU3803593A (en) Compounds
AU7220794A (en) Detergent-package combination
AU5261093A (en) Aminoalkylphenyl compounds
AU4780793A (en) 2-aryl-4-quinolones as antitumor compounds
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU6803494A (en) Anticancer compounds
AU6389494A (en) Tv-projector
AU1274295A (en) Heteroarylpyrroles
AU3048492A (en) New compounds
AU8104694A (en) Bagbottle
AU5394594A (en) New compounds
AU6971594A (en) Cyclobutylazoles
AU6427194A (en) Aza-androstane-17beta -carboxamides
AU3759793A (en) Compounds
AU6169294A (en) 15-oxasterols as hypocholesterolemics
AU5780894A (en) Crankhead
AU3696093A (en) Aquamate
AU7285994A (en) Suncap